Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Teriflunomide in multiple sclerosis: Added benefit not proven
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Flupirtine in pain management: pharmacological properties and clinical use.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Synaptic pathology: a shared mechanism in neurological disease.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.

Pages